When it comes to design, there's a difference in size for the first time since the iPhone Plus made its comeback a couple of years ago. The iPhone 16 Pro Max features a huge 6.9-inch screen, which ...

“If you like big phones and need all the latest and greatest features, it's hard to go wrong with the iPhone 16 Pro Max.” The Apple iPhone 16 Pro Max is the biggest iPhone you can ...

Akebia Therapeutics, Inc. announced that it will present data at the National Kidney Foundation Spring Clinical Meetings 2025 (NKF SCM25) in Boston from April 10-13, 2025. The company will display ...

Akebia Therapeutics' stock is down 28% after a proposed stock offering, with declining Auryxia revenues and significant financial challenges. Vafseo's market launch shows some promise, but it's a ...

In this article, we are going to take a look at where Akebia Therapeutics Inc. (NASDAQ:AKBA) stands against other Thursday’s worst-performing stocks. Wall Street’s main indices edged lower on ...

Prep your wallets, everyone, there’s a new streaming service in town. Warner Bros. Discovery have announced that its incoming ‘Max’ streaming service, which will bring together everything from WB and ...

Akebia Therapeutics shares were down 20% to $2.27 after the company priced its underwritten public offering of 25 million shares at $2 a share. All shares are being offered by Akebia. The proceeds ...

CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Akebia Therapeutics, Inc. before investing. In this article, we go over a few key ...

CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted ...

CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by ...